Weekly News via Email
   Set as homepage | Add to favorites | Customer Service | Subscribe Now | Place an Ad | Contact Us | Sitemap Monday, 07.28.2014
Classifieds
News Archive
Su Mo Tu We Th Fr Sa
 1  2  3
 4  5  6  7  8  9  10
 11  12  13  14  15  16  17
 18  19  20  21  22  23  24
 25  26  27  28  29  30  31
Online Extras
Site Services
Around Bend
Outdoor Fun
Travel Info
Shop Local




Members Of



Poll: Today's Live Poll
Email to a friend | Print this | PDF version | Comments (0 posted) 
  Blogger |   del.icio.us |   digg |   newsvine

Mar 12,2007
Burnham team is successful in stem cell study
by Terri Somers

SAN DIEGO - Scientists at the Burnham Institute for Medical Research said they have used human embryonic stem cells to treat a genetically linked degenerative disease by significantly preserving function and prolonging life in mice.

 

Evan Snyder, Burnham Institute for Medical Research 

Their findings offer insights into a biological pathway that affects a broad array of diseases, which combined afflict one in 5,000 people, said Evan Snyder and Jean-Pyo Lee, the Burnham scientists.

In a peer-reviewed article in the journal Nature Medicine, published online Sunday, the San Diego-based scientists write that they implanted two types of stem cells - human neural stem cells taken from a developing brain and human embryonic stem cells coaxed to become neural stem cells - into mice with Sandhoff disease, a deadly degenerative childhood affliction.

Children with Sandhoff, a form of Tay-Sachs disease, are deficient in an enzyme that helps the body metabolize lipids, a fatty material. A buildup of lipids destroys brain cells that control and coordinate body movement and leads to the deterioration of the brain and spinal cord. Children with the disease often don't see their sixth birthday.

When stem cells were implanted in mice, the onset of symptoms was delayed, well-being and motor function were preserved, and life span was extended 70 percent, according to the article.

The study showed the stem cells migrated throughout the brain, with some replacing damaged nerve cells and transmitting nerve impulses.

This is the first evidence that stem-cell-derived nerve cells may integrate electrically and functionally into a diseased brain, Snyder said.

The transplanted cells also boosted the brain's supply of the enzyme Hex, the housecleaning substance that reduces lipid accumulations.

The treatment also dampened the inflammation that typically occurs in the brain as a result of most degenerative diseases. Inflammation is also thought to play a role in disease progression.

"Our study offers the first evidence that (human embryonic stem cells) employ multiple mechanisms - not just cell replacement - to benefit disease," said Snyder, who runs Burnham's stem cell program.

When the stem cells were transplanted into mice who were also given a drug that permitted the enzymes in the stem cells to work more efficiently, the life span of the mice doubled.

This part of the study highlights how future therapeutic use of stem cells against degenerative disease will likely be multidimensional, using the cells as the glue to hold everything together, Snyder said.

"Our studies suggest that functional neuronal replacement can be complemented and, under some conditions, eclipsed by a range of other stem cell actions that nevertheless exert a number of critical stabilizing forces," Snyder said.

Neither of the human embryonic stem cells created tumors, the article says. And the scientists also noted that they saw no negative reactions by the mouse immune system, which are often prompted by transplanting foreign cells into a body.

The article is the culmination of a long-standing collaboration between the Burnham scientists and Frances Platt and Mylvaganam Jeyakumar of Oxford University in England.

The scientists noted that the stem cells they used were coaxed to evolve and survive in a solution that does not contain animal cells and would therefore likely be acceptable to the Food and Drug Administration. All new drugs and therapies in the United States require FDA approval.

While Sandhoff is a rare disease, it is one of a broad type of diseases in which the body cannot metabolize lipids. Since its genetic link is known, scientists use it in researching an array of other diseases in which the genetic cause still has not been identified.

The Burnham scientists hope their work with Sandhoff disease, for which there is no cure, lays the groundwork for clinical trials.

"Dr. Snyder's team has extended the promise of stem cell therapies to children with special needs, including those with Sandhoff disease," said Fia Richmond, the Santa Barbara, Calif., founder of Children's Neurobiological Solutions, whose son has an undiagnosed neurological disorder.

"The CNS Foundation is proud to have contributed major funding for this project on behalf of the 14 million special-needs children in the United States alone."

Other funding for the four-year study came from the National Institutes of Health, Oxford University, the Wellcome Trust and private philanthropies, including National Tay-Sachs and Allied Diseases Foundation, the Late-Onset Tay-Sachs Foundation, the A-T Children's Project, the Barbara Anderson Foundation for Brain Repair, Project A.L.S., March of Dimes and Hunter's Hope.
2340 times read

Related news
San Diego company's stem cells treat diabetes in mice by Terri Somers posted on Feb 22,2008

Putting science back in public policy by The St. Louis Post-Dispatch posted on Mar 16,2009

Senator Smith votes in favor of stem cell research expansion by Bend_Weekly_News_Sources posted on Apr 12,2007

Sweeping stem cell patents rejected by Terri Somers - CNS posted on Apr 03,2007


Did you enjoy this article? Rating: 5.00Rating: 5.00Rating: 5.00Rating: 5.00Rating: 5.00 (total 18 votes)

Market Information
Breaking News
Most Popular
Most Commented
Featured Columnist
Horoscope Guide
Aquarius Aquarius Libra Libra
Aries Aries Pisces Pisces
Cancer Cancer Sagittarius Sagittarius
Capricorn Capricorn Scorpio Scorpio
Gemini Gemini Taurus Taurus
Leo Leo Virgo Virgo
Local Attractions
Bend Visitors & Convention Bureau
Bend Visitors & Convention Bureau

Mt. Bachelor Resort
Mt. Bachelor Resort

Les Schwab Ampitheater
Les Schwab Ampitheater

Deschutes County Fairgrounds
Deschutes County
Fairgrounds

Tower Theatre
Tower Theatre

The High Desert Museum

Advertisements



Deschutes County

Google  
  Web    BendWeekly.com
© 2006 Bend Weekly News
A .Com Endeavors, Inc. Company.
All Rights Reserved. Terms under
which this service is provided to you.
Please read our Privacy Policy. Contact us.
Bend Weekly News & Event Guide Online
   Save the Net
Advertisement
External sites open in new window,
not endorsed by BendWeekly.com
Subscribe in NewsGator Online
Add to Google Add to MSN Add to My AOL
What are RSS headlines?